Practices in The Network truly operate at the forefront of cancer care. Recently, the cellular therapy team at Virginia Oncology Associates completed the very first myeloma Abcema CAR T-cell infusion in an outpatient, private practice setting in the US. Congratulations to the team on this incredible accomplishment! #Myeloma #CommunityOncology #ClinicalResearch
Congratulations to the cellular therapy team at VOA for completing the first myeloma Abecma CAR T-cell infusion in an outpatient, private practice setting in the United States! Abecma is an IV CAR T-cell medication used to treat adults with relapsed or refractory multiple myeloma when the following conditions have been met: 1) Two or more kinds of treatment have not worked or stopped working AND 2) You've had at least one therapy from each of these drug classes, immunomodulatory agent, proteasome inhibitor, and anti CD38-antibody To learn more about cellular therapies at VOA, visit https://lnkd.in/eVzaVGj4